Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients

    NEXT STORY
    Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
    PREV STORY
    Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System

    author_avatar
    NASDAQ Market News

    Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

    BOSTON, May 31, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel ...

    author_avatar
    NASDAQ Market News

    MPI – Change in Board of directors

    Medical Prognosis Institute A/S ("MPI") hereby announces that Jørgen Bardenfleth in connection with the ...

    author_avatar
    NASDAQ Market News